0717 (0717) Fair Value & Analysis

Financial Services · Market cap HK$418M

0 0717 0717 · HK

PriceHK$0.0620

Fair ValueHK$0.1004

Upside+62.0%

Quality55/100

Evidence: High Range HK$0.1004 – HK$0.1004

Fair value as of: Jul 2, 2026

From 23 valuation models · updated today

Share price −12.7% over the past month.

Price vs Fair Value (12 months)

12‑month range HK$0.0600 – HK$0.1480 · the HK$0.0620 price screens below the HK$0.1004 fair value. As of Jul 2, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

0717 (0717) currently trades at HK$0.0620, while our model-based Fair Value estimate is HK$0.1004 — implying the stock looks roughly 62.0% undervalued today. We read business quality at 55/100 (solid quality), in the Financial Services sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

Over the trailing twelve months, 0717 generated revenue of HK$493M at a net margin of 26.3%. Revenue declined 46.6% year over year. It earns a return on equity of 3.6%. The balance sheet holds a net cash position of HK$2.2B. Fundamentals as of Jul 2, 2026

Key figures & financial health

Revenue (TTM) HK$493M

Revenue growth (YoY) -46.6%

Net margin 26.3%

Return on equity 3.6%

Free cash flow HK$1.0B FY2025

P/E ratio 3.1

More key figures

Operating margin 19.4%

EPS (TTM) HK$0.0100

EPS growth (YoY) -31.5%

Net cash HK$2.2B FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 2, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

0717 reported revenue of HK$329M in FY2025 versus HK$684M in FY2021, a compound −16.7%/yr. Reported net income was HK$147M in FY2025.

Revenue −16.7%/yr

FY21 HK$684M

FY22 HK$168M

FY23 HK$450M

FY24 HK$334M

FY25 HK$329M

Net income

FY21 −HK$576M

FY22 −HK$299M

FY23 −HK$161M

FY24 HK$66.4M

FY25 HK$147M

Is 0717 fairly valued? → Check now

Similar stocks

6 more Credit Services stocks, each showing price versus our Fair Value estimate (as of Jul 2, 2026).

Stock	Price	Fair Value	vs Fair Value
Visa Inc V	5,663 MXN	3,063 MXN	-46%
Mastercard Incorporated MA	C$29.95	C$17.84	-40%
M4I M4I	€430.50	€317.57	-26%
American Express Company AXP	C$28.87	C$17.03	-41%
Capital One Financial Corporation COF	$183.20	$122.33	-33%
Bajaj Finance Limited BAJFINANCE	₹968.30	₹720.78	-26%

Explore undervalued stocks

More undervalued Financial Services stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks

Frequently asked questions

Is 0717 (0717) undervalued?

As of Jul 2, 2026, our model estimates a fair value of HK$0.1004 versus a price of HK$0.0620 — about +62% (undervalued). Model-based estimate, not financial advice.

What is the fair value of 0717?

Our model-based fair value for 0717 is HK$0.1004 (as of Jul 2, 2026), built from audited fundamentals. The current price is HK$0.0620.

What is the quality score of 0717?

0717 has a Quality Score of 55/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

What is the revenue of 0717 (0717)?

0717 reported trailing-twelve-month revenue of about HK$493M (latest available figure, as of Jul 2, 2026).

What is the net profit margin of 0717?

The net profit margin of 0717 is about 26.3%, meaning it keeps roughly 26.3% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.